GlassScriptSerpex Medical INC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$257Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
52clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Joshua Routh | Phoenix, AZ | Anatomic Pathology & Clinical Pathology | $63,535.76 |
| Krishnendu Bhadra | Chattanooga, TN | Pulmonary Disease | $46,898.83 |
| Jeremy Durack | New York, NY | Diagnostic Radiology | $22,280.24 |
| Ali Saeed | Phoenix, AZ | Pulmonary Disease | $16,698.32 |
| Abid Khokar | Phoenix, AZ | Pulmonary Disease | $16,106.05 |
| Michael Pritchett | Pinehurst, NC | Pulmonary Disease | $16,000.00 |
| Eric Seeley | San Francisco, CA | Internal Medicine | $14,194.37 |
| Momen Wahidi | Chicago, IL | Pulmonary Disease | $11,045.24 |
| Glen Weiss | Boston, MA | Medical Oncology | $8,875.00 |
| Mark Onaitis | San Diego, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $8,798.43 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.